glp 1 agonist dpp 4 inhibitor The Role of GLP-1, DPP-4, and SGLT-2 Inhibitors in Diabetes Management Comparison of GLP-1 receptor agonists

Neurological: convulsions, increased intracranial pressure with papilledema (pseudotumor cerebri) usually after treatment, vertigo, headache Endocrine: menstrual irregularities, development of cushingoid state, suppression of fetal intrauterine or childhood growth, lack of secondary response of the adrenal cortex or pituitary gland, particularly in situations of stress such as trauma, surgery or illness, decreased carbohydrate tolerance, manifestations of latent diabetes mellitus, increased requirements of insulin or oral hypoglycemic agents in diabetic patients Ophtalmic: posterior subcapsular cataracts, increased intraocular pressure, glaucoma, exophthalmos Metabolic: negative nitrogen balance due to protein catabolism Psychiatric: euphoria, mood swings, severe depression to frank psychotic manifestations, personality changes, hyperirritability, insomnia Others: anaphylactoid or hypertensive reactions and hypotension or shock-like reaction Cyanocobalamin and hydroxocobalamin: hypervitaminosis and side effects were not observed with their use Dosage and administration Adults Coated tablets: 1 coated tablet 2 times a day

Biochemical assessments were performed using a DSX Best sells 2000 automated ELISA machine

MT-1 shifts the balance

For blood lactate concentration measurements, 20 L of whole blood was mixed with hemolyzing solution (EKF Diagnostic Sales, Magdeburg, Germany) and lactate concentration was measured using the EKF Biosen C-Line Analyser (EKF Diagnostics GmbH, Barleben, Germany)

Superimposing a tonic pharmacological brake on top of this feedback system creates competing signals, and it would be unsurprising if intestinal feedback partially normalized emptying over time even while the drug is present

In contrast, clinical trials have yielded mixed results